Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia. // Advances in Biomarker Sciences and Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all
Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia. Advances in Biomarker Sciences and Technology. https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all
“Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia.” Advances in Biomarker Sciences and Technology.
@article{article33270,
title = {Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia},
journal = {Advances in Biomarker Sciences and Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2543106426000116?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...